HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

899.640

+29.7373.42%

Number of Gainers:6

Number of Losers:4

Number of Flat:3

PE:- -

High:902.356

Open:868.780

Low:861.334

Close:869.902

Volume:54.28M

Turnover:562.52M

Market Cap:149.52B

Float Cap:110.04B

Loading ...

China Medical System Gets China Nod for Lupus Erythematosus Drug Trial

CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate

China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval Notice by Nmpa on Sept 11, 2026

THOMSON REUTERS

3SBIO Allocates HK$3.09 Million to Buy Back 200,000 Shares

Fosun Pharma Spends HK$24.7 Million Buying Back 1.455 Million Shares on September 14

AH Share Premium Rankings as of September 14

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5%

MT Newswires Live

Longchuan Zone of Ruili Industrial Cooperation Park Reports Strong Performance in First Half

Angelalign Announces Extraordinary General Meeting

Angelalign Shareholders to Vote on 1,255,803 RSU Grants to Three Executive Directors at Sept. 30 EGM

Angelalign Grants 1.56 Million Restricted Share Units to Eligible Participants

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

Fosun Pharma Spends Approximately HK$21.86 Million on Share Buyback

3SBio Allocates HK$62.6 Million to Buy Back 4 Million Shares

3SBio Files HKEX Next-Day Disclosure Return Reporting Share Repurchase

HAOHAI BIOTEC Spends Approximately HK$795,700 on Share Buyback

AH Share Premium Rankings: September 10 Market Close Update

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":899.6395,"timestamp":1789373282104,"preClose":869.9022,"halted":0,"volume":54280183,"delay":0,"changeRate":0.034185,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":29.737305,"latestTime":"09-14 16:00:00","open":868.77954,"high":902.35596,"low":861.3339,"amount":562515442,"amplitude":0.047157,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"pbRate":1.117247,"peRate":10.209827,"turnoverRate":0.002666,"increases":6,"decrements":4,"flats":3,"marketCap":149516071320,"floatMarketCap":110036301464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":902.35596,"amplitude":0.047157,"preClose":869.9022,"low":861.3339,"pbRate":"1.117247","latestPrice":899.6395,"volume":54280183,"delay":0,"open":868.77954,"prevYearClose":1094.978,"prevWeekClose":869.902,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":913.448,"twentyDayClose":958.802,"sixtyDayClose":844.161,"secType":"PLATE","market":"HK","turnoverRate":0.002666,"peRate":10.209827,"marketCap":149516071320,"floatMarketCap":110036301464,"timestamp":1789373282104,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":6,"down":4,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667668509","title":"China Medical System Gets China Nod for Lupus Erythematosus Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668509","media":"MT Newswires","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668509?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:12","pubTimestamp":1789384366,"startTime":"0","endTime":"0","summary":"China Medical System Holdings  obtained clinical trial approval for its CMS-D001 tablets from China's National Medical Products Administration.The trial will evaluate the safety and efficacy of CMS-D001 for the treatment of systemic lupus erythematosus, according to a Monday bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b010cf239ffd4765bcd3edd8f767f746","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNQ40.USD","BK6079","IE00BMCWC346.EUR","SG9999004220.SGD","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999004311.SGD","BK1593","SG9999015986.USD","SG9999015945.SGD","IE00BVYPNP33.GBP","IE00BYV24P56.USD","00867","SG9999015978.USD","8A8.SI","LU2488822045.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170311528","title":"CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1170311528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170311528?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:26","pubTimestamp":1789381603,"startTime":"0","endTime":"0","summary":"CMS has announced that its innovative drug candidate, CMS-D001 tablets, received a clinical trial approval notice from China's National Medical Products Administration (NMPA) on September 11, 2026,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","BK1574","BMED","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","SG9999004311.SGD","IE00BGHQDM52.EUR","PSYK","LU2488822045.USD","MDTX","BK1161","06978","BK1593","MEDX","SG9999015952.SGD","SG9999004220.SGD","00867","LNGR","159992","IBBQ","SG9999015986.USD","IE00BYV24P56.USD","BK1191","SG9999015945.SGD","IE00BVYPNQ40.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667571416","title":"China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval Notice by Nmpa on Sept 11, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667571416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667571416?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:21","pubTimestamp":1789381294,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN45501W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00867","BK1191","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","IE00BYV24P56.USD","SG9999015978.USD","LU2488822045.USD","SG9999004220.SGD","BK1593","SG9999015952.SGD","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015945.SGD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151703817","title":"3SBIO Allocates HK$3.09 Million to Buy Back 200,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1151703817","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151703817?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:16","pubTimestamp":1789380976,"startTime":"0","endTime":"0","summary":"3SBIO (HKG: 1530) announced on September 14, 2026, that it utilized approximately HK$3.094 million to repurchase 200,000 of its own shares.The buyback transaction underscores the company's ongoing...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01530","BK1583","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104635509","title":"Fosun Pharma Spends HK$24.7 Million Buying Back 1.455 Million Shares on September 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1104635509","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104635509?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:15","pubTimestamp":1789380920,"startTime":"0","endTime":"0","summary":"Fosun Pharma (HKEX: 02196) has announced that on September 14, 2026, the company repurchased 1.455 million shares at a total cost of HK$24.7051 million.The buyback reflects the company's ongoing...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0187","BK0060","BK0188","BK0183","BK1593","BK0239","600196","BK1191","BK0196","02196","BK0028","BK0175","BK0096","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184658816","title":"AH Share Premium Rankings as of September 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1184658816","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184658816?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:22","pubTimestamp":1789374149,"startTime":"0","endTime":"0","summary":"As of the close on September 14, data shows that NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and TRIUMPH NEW EN (01108) hold the top three positions in the A-H share premium ratio, with premiums of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","BK1190","09976","IE00BF5LJ272.USD","LU0821914370.USD","LU0488056044.USD","BK1125","LU0214875030.USD","IE00BZ08YT58.USD","LU0890818403.SGD","LU0244354667.USD","LU0348767384.USD","BK1209","03143","LU0588546209.SGD","LU1008478684.HKD","LU0052750758.USD","BK1191","LU1770034418.SGD","LU0307460666.USD","03130","LU2008162690.USD","IE00B543WZ88.USD","BK1163","LU0067412154.USD","LU0254981946.USD","00553","03188","BK1214","LU1211504680.USD","IE00B0169L03.USD","LU0269904917.USD","00991","LU0320764755.SGD","LU0561508036.HKD","LU0540923850.HKD","02359","LU0871576103.HKD","LU1808992512.USD","LU2097828474.EUR","BK1562","LU2097828805.USD","BK1560","LU0149534421.HKD","LU0348827113.USD","01057","03750","LU0345780281.USD","LU3063872942.SGD","LU0348805143.USD","LU1046422090.SGD","02475","BK1533","BK1551","LU1152091168.USD","LU0329678170.USD","LU0082770016.USD","LU0140636845.USD","LU0672654166.SGD","LU0149721374.USD","IE0032431581.USD","LU0828237940.HKD","LU0823426308.USD","LU0359202008.SGD","LU0516422952.EUR","LU0589944569.HKD","LU0620787316.HKD","LU0163747925.USD","00300","03678","LU2097828557.USD","LU1481107354.HKD","LU2242644610.SGD","BK1223","BK1112","LU1769817179.HKD","BK1583","IE00B3M56506.USD","LU0516423091.SGD","LU2226246903.HKD","LU0326950275.SGD","LU0345780521.USD","LU1794554557.SGD","HK0001040168.HKD","LU1224709979.USD","LU1282648689.USD","LU0348783233.USD","BK1193","LU1720050803.USD","LU0164865239.USD","LU0348766576.USD","06745","LU2097828714.EUR","LU0823426480.USD","02883","LU0797268264.HKD","HK0000352291.HKD","02691","LU0117841782.USD","LU0417516902.SGD","LU0287142896.SGD","LU0918141887.USD","LU0370786039.SGD","LU1961090484.USD","LU2039709279.SGD","01989","LU1244550494.USD","LU1504937902.USD","LU0165289439.USD","IE00BVYPNP33.GBP","LU0456854461.SGD","03986","LU2177674079.SGD","LU2045819591.USD","LU1880383366.USD","06066","LU1282649067.USD","LU1688375341.USD","LU1282649141.HKD","LU0173614495.USD","LU1115378108.SGD","LU0572944931.SGD","HK0000320264.USD","SG9999002828.SGD","LU0463099449.HKD","LU1064131342.USD","LU0359201885.HKD","LU1303224171.USD","BK1237","LU0918141705.HKD","LU0329678337.USD","IE00B29SXG58.USD","LU0531971595.HKD","HK0000306685.HKD","LU0384037296.USD","LU1282649810.SGD","BK1170","LU0210526637.USD","LU0327786744.USD","LU1105468828.SGD","LU0229945570.USD","03328","LU0314109678.HKD","LU0708995583.HKD","LU1769817096.USD","LU0348814723.USD","BK1198","LU1960683339.HKD","BK1528","BK1554","BK1149","LU0868486357.SGD","SG9999004220.SGD","LU0181495838.USD","01812","02196","399300","LU0979878070.USD","LU0164880469.USD","LU0417516738.SGD","LU1152091754.HKD","IE00B5MMRT66.SGD","LU1242518931.SGD","LU1244550221.USD","BK1249","00811","LU1366334651.USD","SG9999002463.SGD","LU1048596156.SGD","LU0348784397.USD","IE0008368742.USD","02827","LU0456827905.SGD","IE0008369823.USD","159982","LU0106252389.USD","BK1231","03308","HK0000352382.USD","LU0029875118.USD","LU1328277881.USD","LU0431992006.USD","BK1544","IE00BVYPNQ40.USD","LU0516422366.SGD","LU0164939612.USD","EWH","LU1244550577.SGD","LU0791590937.USD","LU0737861772.HKD","HK0000320223.HKD","LU0456846285.SGD","BK1594","BK1505","LU0266512127.USD","LU0072913022.USD","LU0348788117.USD","LU1242518857.USD","BK1116","LU0128522157.USD","LU1255011170.USD","LU0320764599.SGD","BK1592","IE00B031HY20.USD","09981","LU0106959298.USD","IE0034224299.USD","BK1576","LU0543330483.HKD","LU0501845795.SGD","06826","LU0449509016.USD","LU0348816934.USD","LU2125910500.SGD","BK1181","LU0348735423.USD","02218","BK1147","LU0502904849.HKD","LU2399975544.HKD","LU0531970944.HKD","BK1507","LU2476274720.SGD","LU2264538146.SGD","02701","LU1831875114.USD","BK1130","LU0328353924.USD","LU0096374516.USD","LU1719994722.HKD","LU0634319403.HKD","LU0228659784.USD","LU1807302812.USD","BK1161","IE00BMCWC346.EUR","BK1122","LU1988902786.USD","LU0211977185.USD","LU0082770016.SGD","06821","83188","BK1564","LU0231483743.USD","LU1366334578.USD","LU1993786604.SGD","LU1226287529.USD","03968","IE0031814852.USD","SG9999011746.SGD","BK1202","BK1521","BK1530","LU0469268626.HKD","LU2476274308.USD","LU1251922891.USD","BK1110","BK1610","LU0828238088.HKD","SG9999001226.SGD","LU0043850808.USD","01349","LU0880133367.SGD","LU1206782309.USD","IE00BZ08YR35.GBP","LU0516422440.USD","HK0001040143.USD","LU0862451753.SGD","IE00BZ08YS42.EUR","LU0509642566.USD","LU0648948544.HKD","LU0315179316.USD","LU2294711473.HKD","SG9999001093.SGD","01108","02338","BK1515","IE00B031J352.USD","LU1813983027.USD","02899","BK1144","BK1171","LU0737861699.HKD","LU1188198961.HKD","LU0417516571.SGD","LU2394011477.USD","BK1522","01033","LU0607220059.USD","LU0640798160.USD","LU0828237510.HKD","LU0051755006.USD","00042","BK1105","LU1655091616.SGD","00317","LU0791591158.USD","LU2097828631.EUR","BK1141","BK1514","SG9999006597.SGD","LU2778985437.USD","LU1880383440.USD","BK1593","LU0048580855.USD","IE00BYV24P56.USD","LU0886674414.USD","LU1023057109.AUD","83130","LU0348825331.USD","LU0593848301.USD","LU0061477393.USD","02846","LU0228367735.SGD","LU0049853897.USD","LU0455707207.USD","LU0543330566.HKD","LU0266512473.USD","LU0359201612.USD","82846","LU0516423174.USD","02865","SG9999014674.SGD","LU1675838814.USD","BK1546","LU0039217434.USD","IE00BGHQDM52.EUR","07233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184182375","title":"HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=1184182375","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184182375?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:00","pubTimestamp":1789365620,"startTime":"0","endTime":"0","summary":"Shares of innovative drug companies in Hong Kong are trading broadly higher on Tuesday, fueled by bullish clinical data presented at a major oncology conference and renewed optimism around policy...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","IE00BZ08YS42.EUR","LU0417516738.SGD","HK0000165453.HKD","LU1961090484.USD","LU2328871848.SGD","LU0149534421.HKD","MEDX","BK4588","09969","IE00BZ08YR35.GBP","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU0326950275.SGD","LU0417516571.SGD","LU1831875114.USD","LU2097828474.EUR","01530","IE00BPRC5H50.USD","VXUS","LU2399975544.HKD","LU2476274308.USD","06978","IE00B5MMRT66.SGD","LU2488822045.USD","BK1589","BK1574","01177","KCAI","BK1191","BK1161","159992","LU2476274720.SGD","LU0348783233.USD","LU0455707207.USD","IBBQ","LU0607220059.USD","LU2778985437.USD","LU1794554557.SGD","LU0348766576.USD","LU1720050803.USD","LU0348825331.USD","BK1515","BK1521","LNGR","LU0540923850.HKD","KURE","BK1583","BK1593","LU0417516902.SGD","LU0634319403.HKD","LU2097828557.USD","LU0244354667.USD","LU0561508036.HKD","LU1188198961.HKD","LU0348784397.USD","LU2097828805.USD","09926","LU2097828714.EUR","LU2097828631.EUR","LU0348767384.USD","LU2242644610.SGD","LU0348827113.USD","LU0463099449.HKD","LU0502904849.HKD","01801","BK4585","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667637538","title":"Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667637538","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667637538?lang=en_us&edition=fundamental","pubTime":"2026-09-14 12:43","pubTimestamp":1789361006,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration accepted Shanghai Fosun Pharmaceutical's  application for the 120 milligram per vial of HLX14, or recombinant anti-RANKL fully human monoclonal antibody injection, according to a Shanghai bourse filing on the weekend.The pharmaceutical company's Hong Kong shares jumped 5%, while Shanghai shares rose 2% during Monday's midday trade.Fosun's subsidiary, Shanghai Henlius Biotech, developed the drug, which has been approved for marketing in the U.S., the European Union, the U.K. and Canada.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","BK0060","BK0096","BK1191","BK0187","BK1515","BK0028","BK0188","BK0183","600196","BK0196","BK0239","BK0175","02196","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172195316","title":"Longchuan Zone of Ruili Industrial Cooperation Park Reports Strong Performance in First Half","url":"https://stock-news.laohu8.com/highlight/detail?id=1172195316","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172195316?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:00","pubTimestamp":1789203630,"startTime":"0","endTime":"0","summary":"The Longchuan Zone of the Yunnan Ruili Industrial Cooperation Park delivered an impressive set of results in the first half of 2026. Industrial output reached 1.743 billion yuan, marking a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1209","02135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666652209","title":"Angelalign Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666652209","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666652209?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:10","pubTimestamp":1789132230,"startTime":"0","endTime":"0","summary":"Angelalign announces extraordinary general meetingAngelalign Technology will hold an extraordinary general meeting in Shanghai on Sept. 30, 2026.Shareholders will vote on proposed RSU grants totaling ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL5fmybf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1583","BK1100","BK1587","06699"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666522484","title":"Angelalign Shareholders to Vote on 1,255,803 RSU Grants to Three Executive Directors at Sept. 30 EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2666522484","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666522484?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:00","pubTimestamp":1789131608,"startTime":"0","endTime":"0","summary":"Angelalign shareholders to vote on 1,255,803 RSU grants to three executive directors at Sept. 30 EGMShareholders meet on Sept. 30, 2026 to vote on one-time, three-year retrospective RSU grants to thre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL9BXjKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06699","BK1583","BK1100","BK1593","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168838419","title":"Angelalign Grants 1.56 Million Restricted Share Units to Eligible Participants","url":"https://stock-news.laohu8.com/highlight/detail?id=1168838419","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168838419?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129856,"startTime":"0","endTime":"0","summary":"Angelalign (06699) has announced that its board of directors resolved on September 11, 2026, to award a total of 1,563,900 restricted share units to 16 grantees under the post-IPO restricted share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","06699","BK1587","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188259168","title":"Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14","url":"https://stock-news.laohu8.com/highlight/detail?id=1188259168","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188259168?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:50","pubTimestamp":1789120228,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that the drug registration application for its self-developed denosumab biosimilar, HLX14 (recombinant anti-RANKL fully human...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1992135399.USD","LU2272731865.HKD","BK1191","BK0175","IE00B5TLWC47.USD","BK0196","BK1593","BK0012","BK1515","LU1992135472.HKD","02196","XPH","BK0060","LU2272731600.USD","LU2322448957.HKD","BK0187","BK0239","LU2322448791.USD","IBB","BK0028","BK0183","PPH","LU2473716301.USD","BK4585","LU2272731782.SGD","BK0096","BK0188","600196","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147370626","title":"Fosun Pharma Spends Approximately HK$21.86 Million on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1147370626","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147370626?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:38","pubTimestamp":1789119506,"startTime":"0","endTime":"0","summary":"FOSUN PHARMA (02196) announced on September 11 that it repurchased 1.34 million shares for approximately HK$21.8642 million, at a price range of HK$16.14 to HK$16.5 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","02196","BK0187","BK0060","BK0175","BK0028","BK0188","BK1515","600196","BK0096","BK0183","BK1593","BK1191","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194232555","title":"3SBio Allocates HK$62.6 Million to Buy Back 4 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1194232555","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194232555?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:38","pubTimestamp":1789036693,"startTime":"0","endTime":"0","summary":"In a regulatory filing on Wednesday, 3SBio disclosed its latest share repurchase activity, spending approximately HK$62.63 million to acquire 4 million of its own shares on September 10.This buyback...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1583","BK1161","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666673685","title":"3SBio Files HKEX Next-Day Disclosure Return Reporting Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2666673685","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666673685?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:36","pubTimestamp":1789036581,"startTime":"0","endTime":"0","summary":"3SBio files HKEX next-day disclosure return reporting share repurchase3SBio repurchased 4,000,000 ordinary shares on Sept. 10, 2026, holding them as treasury shares.Buyback range HKD 15.5 to HKD 15.75","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL4fyG9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01530","BK1593","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117842310","title":"HAOHAI BIOTEC Spends Approximately HK$795,700 on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1117842310","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117842310?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:44","pubTimestamp":1789033451,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) announced that on September 10, 2026, it utilized approximately HK$795,700 to repurchase 48,000 shares of the company.The buyback transaction reflects the company's ongoing...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120089169","title":"AH Share Premium Rankings: September 10 Market Close Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1120089169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120089169?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:23","pubTimestamp":1789028611,"startTime":"0","endTime":"0","summary":"As of the market close on September 10, data reveals the latest rankings for A-H share premium ratios, with NE Electric (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) claiming the top...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910500.SGD","LU1152091754.HKD","LU0868486357.SGD","02865","LU1328277881.USD","BK1149","LU0345780521.USD","LU0165289439.USD","LU0210526637.USD","LU0823426308.USD","LU0348766576.USD","LU1244550221.USD","LU0287142896.SGD","LU0061477393.USD","03678","01812","LU1675838814.USD","LU0348827113.USD","01349","03986","BK1593","LU1115378108.SGD","LU0149534421.HKD","06066","LU0880133367.SGD","BK1610","LU0229945570.USD","LU1880383440.USD","LU0828237510.HKD","03328","BK1198","BK1521","LU2097828805.USD","LU1481107354.HKD","LU0648948544.HKD","IE00B031J352.USD","LU0821914370.USD","LU0320764599.SGD","03188","BK1564","LU0918141887.USD","HK0000306685.HKD","LU0572944931.SGD","LU0890818403.SGD","LU1226287529.USD","LU0106252389.USD","LU0266512473.USD","SG9999014674.SGD","00300","LU1719994722.HKD","LU0823426480.USD","LU1064131342.USD","LU0163747925.USD","LU0269904917.USD","IE00BMCWC346.EUR","IE0008368742.USD","LU0828238088.HKD","LU0737861699.HKD","LU1188198961.HKD","LU0315179316.USD","LU1048596156.SGD","83188","LU0516423091.SGD","BK1523","IE00B29SXG58.USD","BK1551","BK1507","LU1831875114.USD","BK1583","LU0593848301.USD","LU0469268626.HKD","06821","IE00B031HY20.USD","BK1546","LU0327786744.USD","01877","HK0001040143.USD","LU1211504680.USD","LU0307460666.USD","HK0000320264.USD","LU1242518857.USD","03200","82846","SG9999011746.SGD","IE00BYV24P56.USD","BK1191","BK1594","LU1720050803.USD","LU0502904849.HKD","BK1552","00187","LU2097828714.EUR","LU0173614495.USD","06185","IE0032431581.USD","LU1770034418.SGD","LU2039709279.SGD","LU0348805143.USD","LU0244354667.USD","LU0509642566.USD","LU0886674414.USD","HK0001040168.HKD","LU0140636845.USD","LU1303224171.USD","SG9999004220.SGD","LU0266512127.USD","LU2097828557.USD","BK1514","LU0329678170.USD","BK1223","LU0607220059.USD","03308","BK1171","LU0370786039.SGD","LU0314109678.HKD","LU2294711473.HKD","IE00B543WZ88.USD","LU1244550494.USD","BK1214","IE0034224299.USD","LU0417516738.SGD","SG9999001226.SGD","LU0979878070.USD","LU0228367735.SGD","LU0456854461.SGD","LU0828237940.HKD","LU0634319403.HKD","LU2399975544.HKD","LU1224709979.USD","LU0516422366.SGD","LU2097828474.EUR","LU0096374516.USD","LU0072913022.USD","IE00B0169L03.USD","159982","LU0384037296.USD","LU0797268264.HKD","LU2177674079.SGD","BK1147","IE00BVYPNQ40.USD","BK1163","LU0672654166.SGD","00042","LU0117841782.USD","LU0791590937.USD","BK1506","LU0211977185.USD","HK0000352291.HKD","LU2264538146.SGD","LU0106959298.USD","399300","LU1366334578.USD","00317","BK1170","LU0328353924.USD","HK0000306701.USD","LU3063872942.SGD","IE00BZ08YS42.EUR","LU0214875030.USD","BK1554","01033","LU1366334651.USD","LU0254981946.USD","BK1116","LU1993786604.SGD","01057","LU0048580855.USD","06745","BK1105","LU0620787316.HKD","BK1110","LU2045819591.USD","SG9999002463.SGD","03750","LU0417516902.SGD","LU0051755006.USD","LU0231483743.USD","HK0000352382.USD","LU1206782309.USD","BK1522","LU0164880469.USD","LU1255011170.USD","SG9999001093.SGD","LU0039217434.USD","LU1807302812.USD","LU1960683339.HKD","BK1505","LU2226246903.HKD","LU2476274720.SGD","LU0640798160.USD","LU0543330566.HKD","BK1249","00895","01108","BK1231","BK1125","IE00BF5LJ272.USD","06869","LU1282649141.HKD","LU1769817179.HKD","06826","LU1282648689.USD","LU0326950275.SGD","LU0320764755.SGD","LU0359202008.SGD","EWH","LU1282649067.USD","BK1140","LU0345780281.USD","02846","BK1530","LU0359201885.HKD","LU1880383366.USD","LU1105468828.SGD","LU1988902786.USD","LU0348788117.USD","03968","IE00BZ08YT58.USD","BK1237","LU0348767384.USD","LU0067412154.USD","LU0455707207.USD","LU2778985437.USD","LU0082770016.SGD","03143","LU0029875118.USD","LU0348825331.USD","BK1122","02068","02218","LU0543330483.HKD","LU0862451753.SGD","BK1144","SG9999002828.SGD","LU0348735423.USD","LU0531971595.HKD","LU1152091168.USD","BK1592","IE0008369823.USD","IE00BVYPNP33.GBP","LU0431992006.USD","BK1560","IE00B5MMRT66.SGD","LU1242518931.SGD","BK1161","02475","LU0359201612.USD","BK1202","LU0708995583.HKD","LU0463099449.HKD","SG9999006597.SGD","LU0128522157.USD","BK1576","LU0488056044.USD","LU0589944569.HKD","LU0531970944.HKD","BK1141","02899","LU1282649810.SGD","LU0228659784.USD","02359","LU0348816934.USD","BK1515","LU2097828631.EUR","LU0501845795.SGD","BK1574","07233","LU0791591158.USD","LU0348814723.USD","LU0181495838.USD","LU1794554557.SGD","LU1688375341.USD","00553","LU1008478684.HKD","83130","IE00BGHQDM52.EUR","LU0329678337.USD","LU0516423174.USD","LU1023057109.AUD","LU0588546209.SGD","BK1183","00991","LU1046422090.SGD","LU0149721374.USD","LU0082770016.USD","LU0871576103.HKD","BK1148","LU2394011477.USD","IE00B3M56506.USD","BK1533","BK1562","LU2476274308.USD","LU0561508036.HKD","LU0164865239.USD","LU0516422440.USD","LU0516422952.EUR","LU2008162690.USD","LU1251922891.USD","LU1504937902.USD","LU0164939612.USD","BK1544","LU1813983027.USD","LU2242644610.SGD","02338","LU0737861772.HKD","LU0052750758.USD","LU1769817096.USD","IE0031814852.USD","LU1655091616.SGD","LU0456846285.SGD","LU1244550577.SGD","LU0449509016.USD","LU0456827905.SGD","02827","BK1190","LU1961090484.USD","LU0540923850.HKD","IE00BZ08YR35.GBP","03130","LU0043850808.USD","BK1537","LU0918141705.HKD","HK0000320223.HKD","LU1808992512.USD","LU0049853897.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169429326","title":"Pharmaceutical Firms Divest Assets to Bolster Core Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1169429326","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169429326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:12","pubTimestamp":1788966731,"startTime":"0","endTime":"0","summary":"A growing number of domestic listed pharmaceutical companies have recently disclosed asset disposal announcements, planning to sell partial or full equity stakes in their controlled subsidiaries....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOSL","BK1515","BK1574","BK1191","02196","BK4202","BK1161","09939","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108076077","title":"Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1108076077","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108076077?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:21","pubTimestamp":1788956512,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. has announced that its oral candidate FXS5626 tablets (formerly project code AC-201) have received clinical trial approval from the National Medical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0028","BK1515","02196","BK0196","BK0183","BK0012","BK0239","BK1191","BK1593","BK0188","600196","BK0060","BK0187","BK0175"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}]}}